Literature DB >> 12652003

Animal models of focal and global cerebral ischemia.

Richard J Traystman1.   

Abstract

The use of appropriate animal models is essential to predict the value and effect of therapeutic approaches in human subjects. Focal (stroke) and global (cardiac arrest) cerebral ischemia represents diseases that are common in the human population. Stroke and cardiac arrest, which are major causes of death and disability, affect millions of individuals around the world and are responsible for the leading health care costs of all diseases. Understanding the mechanisms of injury and neuroprotection in these diseases is critical if we are ever to learn new target sites to treat ischemia. There are many animal models available to investigate injury mechanisms and neuroprotective strategies. This review summarizes many (but not all) small and large animal models of focal and global cerebral ischemia and discusses their advantages and disadvantages.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12652003     DOI: 10.1093/ilar.44.2.85

Source DB:  PubMed          Journal:  ILAR J        ISSN: 1084-2020


  114 in total

1.  Autophagy in neurite injury and neurodegeneration: in vitro and in vivo models.

Authors:  Charleen T Chu; Edward D Plowey; Ruben K Dagda; Robert W Hickey; Salvatore J Cherra; Robert S B Clark
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

Review 2.  Executive (dys)function after stroke: special considerations for behavioral pharmacology.

Authors:  Jessica M Povroznik; Jenny E Ozga; Cole Vonder Haar; Elizabeth B Engler-Chiurazzi
Journal:  Behav Pharmacol       Date:  2018-10       Impact factor: 2.293

Review 3.  Rodent Gymnastics: Neurobehavioral Assays in Ischemic Stroke.

Authors:  Sreekala S Nampoothiri; Tanvi Potluri; Harshith Subramanian; Rajanikant G Krishnamurthy
Journal:  Mol Neurobiol       Date:  2016-10-17       Impact factor: 5.590

Review 4.  Integration of cytokine biology and lipid metabolism in stroke.

Authors:  Rao Muralikrishna Adibhatla; Robert Dempsy; James Franklin Hatcher
Journal:  Front Biosci       Date:  2008-01-01

5.  Three-dimensional time-of-flight magnetic resonance angiography of intracranial vessels in a canine model of ischemic stroke with permanent occlusion of the middle cerebral artery.

Authors:  Byeong-Teck Kang; Dong-Pyo Jang; Su-Hyun Gu; Young-Bo Kim; Chae-Young Lim; Jong-Hwan Lee; Eung-Je Woo; Zang-Hee Cho; Hee-Myung Park
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

6.  Effects of buprenorphine and meloxicam analgesia on induced cerebral ischemia in C57BL/6 male mice.

Authors:  Kirsten R Jacobsen; Natasha Fauerby; Zindy Raida; Otto Kalliokoski; Jann Hau; Flemming F Johansen; Klas Sp Abelson
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

7.  Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke.

Authors:  Ran Liu; Qing Liu; Shaoqing He; James W Simpkins; Shao-Hua Yang
Journal:  J Pharmacol Exp Ther       Date:  2009-12-01       Impact factor: 4.030

Review 8.  Stroke, Vascular Dementia, and Alzheimer's Disease: Molecular Links.

Authors:  Murali Vijayan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2016-09-06       Impact factor: 4.472

Review 9.  The role of the ubiquitin proteasome system in ischemia and ischemic tolerance.

Authors:  Robert Meller
Journal:  Neuroscientist       Date:  2009-01-30       Impact factor: 7.519

10.  Stereo-selective neuroprotection against stroke with vitamin A derivatives.

Authors:  Yu Sato; Robert Meller; Tao Yang; Waro Taki; Roger P Simon
Journal:  Brain Res       Date:  2008-09-18       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.